BriaCell Therapeutics Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BCTX research report →
About the company
BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company primarily focused on developing innovative immunotherapies to combat cancer. The firm's leading experimental drug, Bria-IMT, is currently undergoing Phase I/IIa clinical investigation.
- CEO
- William V. Williams
- IPO
- 2012
- Employees
- 16
- HQ
- West Vancouver, BC, CA
Price Chart
- Market Cap
- $6.14M
- P/E
- -0.26
- P/S
- 0.00
- P/B
- 0.97
- EV/EBITDA
- 0.03
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -147.92%
- ROIC
- -136.31%
- Revenue
- $0 · 0.00%
- Net Income
- $-36,493,821 · -661.35%
- EPS
- $-62.60 · -45.55%
- Op Income
- $-37,732,298
- FCF YoY
- -16.32%
- 52W High
- $30.00
- 52W Low
- $2.60
- 50D MA
- $3.49
- 200D MA
- $6.51
- Beta
- 1.54
- Avg Volume
- 202.03K
Get TickerSpark's AI analysis on BCTX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 14, 24 | Lustig Marc | buy | 902,935 |
| May 14, 24 | Lustig Marc | buy | 902,935 |
| Dec 28, 22 | Bondarenko Jamieson | buy | 28,000 |
| Dec 23, 22 | Williams William V. | buy | 2,530 |
| Dec 20, 22 | Bondarenko Jamieson | buy | 22,000 |
| Aug 1, 22 | Bondarenko Jamieson | other | 0 |
| Aug 1, 22 | Bondarenko Jamieson | other | 250,000 |
| Aug 12, 21 | Bondarenko Jamieson | other | 70,000 |
| Mar 29, 21 | Bondarenko Jamieson | other | 150,000 |
| Aug 1, 22 | Lustig Marc | other | 0 |
Our BCTX coverage
Recent articles, reports, and earnings notes.
No research on BCTX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BCTX report →Similar companies
Peers in the same neighborhood.